Last update 01 Nov 2024

BEY-1107P

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Avotaciclib, BEY-A
+ [3]
Target
CDK1
Mechanism
CDK1 inhibitors(Cyclin-dependent kinase 1 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersNervous System Diseases+ [1]
Active Indication
Metastatic Colorectal CarcinomaGlioblastoma MultiformeRecurrent Glioblastoma
Inactive Indication
Pancreatic Cancer
Originator Organization
Beyondbio, Inc.Beyondbio, Inc.
Active Organization
Beyondbio, Inc.Beyondbio, Inc.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC13H11N7O
InChIKeyVFVAQKKPFOPZEA-UHFFFAOYSA-N
CAS Registry1983983-41-0

Related

3
Clinical Trials associated with BEY-1107P
NCT05769660 / RecruitingPhase 1
An Open-label, Phase I Clinical Trial to Assess the Maximum Tolerated Dose (MTD), Safety and Efficacy of BEY1107 in Combination With Temozolomide in Patient With Recurrent or Progressive Glioblastoma Multiforme (GBM)
NCT05093907 / RecruitingPhase 1/2
An Open-label, Single Center, Phase I/II Clinical Trial to Assess the Maximum Tolerated Dose, Safety and Efficacy of BEY1107 in Combination With Capecitabine in Patients With Metastatic Colorectal Cancer Refractory or Intolerant to Standard of Care
NCT03579836 / Unknown statusPhase 1/2
A Single Center, Open-label, Non-comparative, Phase I/II Clinical Trial to Assess the MTD, Safety and Efficacy of BEY1107 in Monotherapy and in Combination With Gemcitabine in Patient With Locally Advanced or Metastatic Pancreatic Cancer
100 Clinical Results associated with BEY-1107P
Login to view more data
100 Translational Medicine associated with BEY-1107P
Login to view more data
100 Patents (Medical) associated with BEY-1107P
Login to view more data
100 Deals associated with BEY-1107P
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Colorectal CarcinomaPhase 2
KR
Beyondbio, Inc.Beyondbio, Inc.
31 Aug 2021
Glioblastoma MultiformePhase 1
KR
Beyondbio, Inc.Beyondbio, Inc.
29 Nov 2022
Recurrent GlioblastomaPhase 1
KR
Beyondbio, Inc.Beyondbio, Inc.
29 Nov 2022
Pancreatic CancerPreclinical
KR
Beyondbio, Inc.Beyondbio, Inc.
01 May 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free